genedrive plc (AIM:GDR)

Market Cap	19.27M +319.5%
Revenue (ttm)	1.17M +91.5%
Net Income	-5.34M
EPS	-0.01
Shares Out	1.61B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,090,861
Open	1.150
Previous Close	1.200
Day's Range	1.150 - 1.250
52-Week Range	0.190 - 1.500
Beta	0.97
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 4, 2026

About genedrive

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 43
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: GDR

Financial Performance

In fiscal year 2025, genedrive's revenue was 954,000, an increase of 90.42% compared to the previous year's 501,000. Losses were -5.23 million, -26.06% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 17, 2026

Data Sources Report a data error